43
BioTOPics 47 | May 2014
BioTOP-Report
Addresses
Pharmaceutical Companies
BERLIN-CHEMIE
Aktiengesellschaft
BERLIN-CHEMIE is a German subsidiary of the MENARINI Group. The company,
which was formed in 1886 and is headquartered in Florence, was developed over
the generations to become a global, owner-managed pharmaceutical company. Re-
search is centred on the development of innovative drugs for the following areas:
inflammatory diseases and pain, cardiovascular diseases, oncology, viral disease.
berlin-chemie.de
Chemisch-pharmazeutisches
Labor, Rolf Sachse GmbH
CPL S: Custom synthesis development of active pharmaceutical ingredients (API’s),
Contract manufacture of active pharmaceutical ingredients from laboratory to kilo-
scale, Pharmaceutical analysis.
cpl-sachse.de
Daiichi Sankyo
Daiichi Sankyo is a global pharmaceutical company with corporate origins in Japan.
We provide innovative products and services in more than 50 countries around the
world. With more than 100 years of scientific expertise, our company draws upon
a rich legacy of innovation and a robust pipeline of promising new medicines to
help patients. Through the outstanding knowledge and commitment of our 30,000
employees worldwide, we create innovative new and generic medicines, and new
methods of drug discovery and delivery. We share a passion for innovation, as well
as compassion for the patients around the world who are in need of our medicines.
daiichisankyo.com
Dr. Kade Pharmazeutische Fabrik
GmbH
The company’s activities concentrate on the production and marketing of drugs in
the fields of gynecology, proctology, pain relief/ rheumatism and urology. The poten-
tial of proven drugs is expanded systematically by galenic developments to produce
innovative products.
kade.de
Haupt Pharma AG
With ,nine production sites Haupt Pharma is one of the leading contract man-
ufacturers for pharmaceutical products in ,the world ,today. ,About
2.000 ,employees produce for an established clientele of more than 200 im-
portant international pharmaceutical companies, amongst which 15 of the interna-
tional TOP 25.
haupt-pharma.de
Heyl chemisch pharmazeutische
Fabrik GmbH & Co. KG
HEYL is an independent, entrepreneurial family business that has its headquarters in
probably the liveliest German metropolis, Berlin, since its establishment in 1926. In
cooperation with our international subsidiaries, the main focuses of our work are the
Regulatory Affairs and marketing of medicines as well as the sale of active pharma-
ceutical ingredients (API's) and special chemicals.
heyl-berlin.com
Klosterfrau Berlin GmbH
For more than 175 years Klosterfrau has been developing, manufacturing and mar-
keting pharmaceutical products. The profile of traditional yet modern natural med-
icines has grown significantly in recent times. Based on the latest scientific discov-
eries combined with the development of new markets, the range is constantly being
expanded with innovative products.
klosterfrau.de
medphano Arzneimittel GmbH
medphano Arzneimittel in Rüdersdorf stands for proven and cost-effective phar-
maceutical preparations. Main products are analgesics/anti-rheumatics, antibiotics,
dermatics, diuretics, drugs to stimulate blood circulation, drugs for treatment of gas-
tro-intestinal disorders, vitamins, expectorants, lipid-lowering agents, ophthalmics,
cosmetics, food supplements, diet foods and foods.
medphano.de
MUCOS Pharma GmbH & Co.KG
As a specialist in enzyme preparations Mucos supplies a steadily growing market
with specific and variably dosed enzyme combinations. The company leads the
world market in oral enzymes for therapeutic purposes.
mucos.de
Pfizer Pharma GmbH
Pfizer is the world's largest research-based biomedical and pharmaceutical com-
pany.
pfizer.de
Pharma Action GmbH
Pharma Action has extensive expertise in global pharmaceutical marketing and man-
ufacturing since 1988 and offers cutting edge API solutions to the pharmaceutical
industry in Europe and abroad.
pharma-action.com
PharmaMar GmbH
PharmaMar is a biopharmaceutical subsidiary of Grupo Zeltia; it is a world leader in
discovering, developing and marketing marine-based drugs to treat cancer. Yondel-
is
®
is the first marine-based antitumour drug. PharmaMar has four other compounds
in clinical development: Aplidin
®
, Zalypsis
®
, PM01183 and PM060184. PharmaMar
also has a rich pipeline of pre-clinical candidates and a major R&D programme.
PharmaMar GmbH, the German subsidiary, was officially established in November
2013 in Berlin.
pharmamar.com
Piramal Imaging GmbH
Piramal Imaging is a start-up business within the Life-Science division of the Mum-
bai-based Piramal Enterprises Group. The company is dedicated to the clinical re-
search & development and the global commercialization of Nuclear Medicine / Mo-
lecular Imaging products for detection, characterization and monitoring of disabling
and life-threatening diseases in neurology, oncology and the cardio-vascular space.
imaging.piramalenterprises.
com
Sanofi-Aventis Deutschland
GmbH
Sanofi-aventis is a leading global pharmaceutical company based in Paris and oper-
ating in over 100 countries. R&,D teams work on a global approach to patients,
offering innovative therapeutic strategies in thrombosis, cardiovascular diseases,
diabetes, vaccines, oncology, the central nervous system disorders and internal
medicine.
sanofi-aventis.de
Shire Deutschland GmbH
Shire’s strategic goal is to become the leading specialty biopharmaceutical compa-
ny that focuses on meeting the needs of the specialist physician. Shire focuses its
business on attention deficit and hyperactivity disorder, human genetic therapies and
gastrointestinal diseases.
shire.de